Antengene's Series A Round

Antengene raised a round of funding on August 16, 2017.

Antengene (德琪医药) is a Chinese clinical-stage biopharmaceutical firm focusing on introducing treatments, from mid-to-late development stage pipeline to mature brands, to China and other Asian m…

Articles about Antengene's Series A Round: